Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Contrast Media Mol Imaging ; 2018: 1269830, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29666562

RESUMEN

Molecular imaging probes such as PET-tracers have the potential to improve the accuracy of tumor characterization by directly visualizing the biochemical situation. Thus, molecular changes can be detected early before morphological manifestation. The A3 adenosine receptor (A3AR) is described to be highly expressed in colon cancer cell lines and human colorectal cancer (CRC), suggesting this receptor as a tumor marker. The aim of this preclinical study was the evaluation of [18F]FE@SUPPY as a PET-tracer for CRC using in vitro imaging and in vivo PET imaging. First, affinity and selectivity of FE@SUPPY and its metabolites were determined, proving the favorable binding profile of FE@SUPPY. The human adenocarcinoma cell line HT-29 was characterized regarding its hA3AR expression and was subsequently chosen as tumor graft. Promising results regarding the potential of [18F]FE@SUPPY as a PET-tracer for CRC imaging were obtained by autoradiography as ≥2.3-fold higher accumulation of [18F]FE@SUPPY was found in CRC tissue compared to adjacent healthy colon tissue from the same patient. Nevertheless, first in vivo studies using HT-29 xenografts showed insufficient tumor uptake due to (1) poor conservation of target expression in xenografts and (2) unfavorable pharmacokinetics of [18F]FE@SUPPY in mice. We therefore conclude that HT-29 xenografts are not adequate to visualize hA3ARs using [18F]FE@SUPPY.


Asunto(s)
Neoplasias Colorrectales/diagnóstico por imagen , Ácidos Nicotínicos/farmacocinética , Tomografía de Emisión de Positrones/métodos , Animales , Radioisótopos de Flúor , Células HT29 , Xenoinjertos , Humanos , Ratones , Imagen Molecular/métodos , Proteínas de Neoplasias/análisis , Proteínas de Neoplasias/metabolismo , Radiofármacos/farmacocinética , Receptor de Adenosina A3/análisis , Receptor de Adenosina A3/metabolismo
2.
Eur J Nucl Med Mol Imaging ; 42(6): 928-39, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25739834

RESUMEN

PURPOSE: Since the adenosine A3 receptor (A3R) is considered to be of high clinical importance in the diagnosis and treatment of ischaemic conditions (heart and brain), glaucoma, asthma, arthritis, cancer and inflammation, a suitable and selective A3R PET tracer such as [(18)F]FE@SUPPY would be of high clinical value for clinicians as well as patients. A3R was discovered in the late 1990s, but there is still little known regarding its distribution in the CNS and periphery. Hence, in autoradiographic experiments the distribution of A3R in human brain and rat tissues was investigated and the specific binding of the A3R antagonist FE@SUPPY and MRS1523 compared. Immunohistochemical staining (IHC) experiments were also performed to validate the autoradiographic findings. METHODS: For autoradiographic competition experiments human post-mortem brain and rat tissues were incubated with [(125)I]AB-MECA and highly selective compounds to block the other adenosine receptor subtypes. Additionally, IHC was performed with an A3 antibody. RESULTS: Specific A3R binding of MRS1523 and FE@SUPPY was found in all rat peripheral tissues examined with the highest amounts in the spleen (44.0% and 46.4%), lung (44.5% and 45.0%), heart (39.9% and 42.9%) and testes (27.4% and 29.5%, respectively). Low amounts of A3R were found in rat brain tissues (5.9% and 5.6%, respectively) and human brain tissues (thalamus 8.0% and 9.1%, putamen 7.8% and 8.2%, cerebellum 6.0% and 7.8%, hippocampus 5.7% and 5.6%, caudate nucleus 4.9% and 6.4%, cortex 4.9% and 6.3%, respectively). The outcome of the A3 antibody staining experiments complemented the results of the autoradiographic experiments. CONCLUSION: The presence of A3R protein was verified in central and peripheral tissues by autoradiography and IHC. The specificity and selectivity of FE@SUPPY was confirmed by direct comparison with MRS1523, providing further evidence that [(18)F]FE@SUPPY may be a suitable A3 PET tracer for use in humans.


Asunto(s)
Antagonistas del Receptor de Adenosina A3/farmacocinética , Ácidos Nicotínicos/farmacocinética , Piridinas/farmacocinética , Receptor de Adenosina A3/metabolismo , Antagonistas del Receptor de Adenosina A3/farmacología , Animales , Encéfalo/diagnóstico por imagen , Encéfalo/metabolismo , Humanos , Ácidos Nicotínicos/farmacología , Unión Proteica , Piridinas/farmacología , Radiografía , Ratas , Distribución Tisular
3.
Appl Radiat Isot ; 70(10): 2287-94, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22858577

RESUMEN

The melanin concentrating hormone (MCH) system is a new target to treat human disorders. Our aim was the preparation of the first PET-tracer for the MCHR1. [(11)C]SNAP-7941 is a carbon-11 labeled analog of the published MCHR1 antagonist SNAP-7941. The optimum reaction conditions were 2 min reaction time, ≤25°C reaction temperature, and 2 mg/mL precursor (SNAP-acid) in acetonitrile, using [(11)C]CH(3)OTf as methylation agent. [(11)C]SNAP-7941 was prepared in a reliable and feasible manner with high radiochemical yields (2.9±1.6 GBq; 11.5±6.4% EOB, n=15).


Asunto(s)
Radioisótopos de Carbono/química , Piperidinas/síntesis química , Tomografía de Emisión de Positrones , Pirimidinas/síntesis química , Receptores de Somatostatina/metabolismo , Humanos , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Control de Calidad
4.
Surgery ; 111(1): 74-8, 1992 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1728078

RESUMEN

A marked release of glutaraldehyde from commercially available pericardial bioprosthetic heart valve (BHV) material in washing solutions was found by high performance liquid chromatography (up to 1.8 ppm of glutaraldehyde per gram of dry tissue). In vitro endothelial cell proliferation rate was impaired dose-dependently in the presence of increasing glutaraldehyde concentrations of the cultivation medium (r = 0.9; p less than 0.05). Cultivation of endothelial cells was impossible on the surface of commercially available BHV material, but successful and uninhibited when toxic glutaraldehyde ligands of the BHV material were antagonized by treatment with L-glutamic acid.


Asunto(s)
Materiales Biocompatibles/química , Bioprótesis , Glutaral/farmacología , Prótesis Valvulares Cardíacas , Animales , Bovinos , División Celular/efectos de los fármacos , Células Cultivadas , Endotelio Vascular/citología , Glutaral/análisis , Ensayo de Materiales
7.
Arch Pharm (Weinheim) ; 323(10): 881-2, 1990 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-2127881

RESUMEN

Bioprosthetic heart valves prepared from glutaraldehyde-pretreated bovine pericardium are used to replace diseased human cardiac valves. Mineralisation in the course of time and toxic effects are possibly caused by glutaraldehyde residues. Different washing methods carried out before transplantation are compared with regard to the different ability of glutaraldehyde extraction.


Asunto(s)
Bioprótesis , Glutaral/análisis , Prótesis Valvulares Cardíacas , Animales , Bovinos
8.
Arch Pharm (Weinheim) ; 323(6): 367-73, 1990 Jun.
Artículo en Alemán | MEDLINE | ID: mdl-2396894

RESUMEN

Starting from the corresponding amines the syntheses of various norbornyl ureas with potential fungicidal activity are described. These new compounds possess a tricyclo[5.2.1.0(2,6)]decane, or an isocamphenilane, a camphenilane, an exo- and endo- dimethylnorbornane or a bicyclo[2.2.2]octane carbon skeleton. With the exception of the first class all other derivatives bear a geminal dimethyl group--important because of its shielding effect--at C-3 of the bicyclus. Some ureas, especially 6 and the acetamide 5, are active against phytopathogenic fungi.


Asunto(s)
Fungicidas Industriales/síntesis química , Norbornanos/síntesis química , Ascomicetos/efectos de los fármacos , Fenómenos Químicos , Química , Pruebas de Sensibilidad Microbiana , Norbornanos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA